| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alternatives to the standard Fleming, Harrington, and O’Brien futility boundary
|
Anderson, James R
|
|
2011
|
8 |
3 |
p. 270-276
|
artikel
|
| 2 |
Alternatives to the standard Fleming, Harrington, and O’Brien futility boundary
|
Anderson, James R
|
|
2011
|
8 |
3 |
p. 270-276
|
artikel
|
| 3 |
Beyond the 3+3 method: expanded algorithms for dose- escalation in Phase I oncology trials of two agents
|
Braun, Thomas M
|
|
2011
|
8 |
3 |
p. 247-259
|
artikel
|
| 4 |
Beyond the 3+3 method: expanded algorithms for dose- escalation in Phase I oncology trials of two agents
|
Braun, Thomas M
|
|
2011
|
8 |
3 |
p. 247-259
|
artikel
|
| 5 |
Book Review
|
|
|
2011
|
8 |
3 |
p. 353-354
|
artikel
|
| 6 |
Book Review
|
|
|
2011
|
8 |
3 |
p. 353-354
|
artikel
|
| 7 |
Clinician-trialist rounds: 4. Why not do an N-of-1 RCT?
|
Sackett, David L
|
|
2011
|
8 |
3 |
p. 350-352
|
artikel
|
| 8 |
Clinician-trialist rounds: 4. Why not do an N-of-1 RCT?
|
Sackett, David L
|
|
2011
|
8 |
3 |
p. 350-352
|
artikel
|
| 9 |
Erratum
|
|
|
2011
|
8 |
3 |
p. 355-355
|
artikel
|
| 10 |
Erratum
|
|
|
2011
|
8 |
3 |
p. 355
|
artikel
|
| 11 |
How to use marginal structural models in randomized trials to estimate the natural direct and indirect effects of therapies mediated by causal intermediates
|
Oba, Koji
|
|
2011
|
8 |
3 |
p. 277-287
|
artikel
|
| 12 |
How to use marginal structural models in randomized trials to estimate the natural direct and indirect effects of therapies mediated by causal intermediates
|
Oba, Koji
|
|
2011
|
8 |
3 |
p. 277-287
|
artikel
|
| 13 |
Monitoring the quality of conduct of clinical trials: a survey of current practices
|
Morrison, Briggs W
|
|
2011
|
8 |
3 |
p. 342-349
|
artikel
|
| 14 |
Monitoring the quality of conduct of clinical trials: a survey of current practices
|
Morrison, Briggs W
|
|
2011
|
8 |
3 |
p. 342-349
|
artikel
|
| 15 |
Providing the results of research to participants: a mixed-method study of the benefits and challenges of a consultative approach
|
Dixon-Woods, Mary
|
|
2011
|
8 |
3 |
p. 330-341
|
artikel
|
| 16 |
Providing the results of research to participants: a mixed-method study of the benefits and challenges of a consultative approach
|
Dixon-Woods, Mary
|
|
2011
|
8 |
3 |
p. 330-341
|
artikel
|
| 17 |
Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials
|
Pond, Gregory R
|
|
2011
|
8 |
3 |
p. 260-269
|
artikel
|
| 18 |
Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials
|
Pond, Gregory R
|
|
2011
|
8 |
3 |
p. 260-269
|
artikel
|
| 19 |
Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned
|
Steel, Jennifer
|
|
2011
|
8 |
3 |
p. 298-310
|
artikel
|
| 20 |
Randomized controlled trial of a collaborative care intervention to manage cancer-related symptoms: lessons learned
|
Steel, Jennifer
|
|
2011
|
8 |
3 |
p. 298-310
|
artikel
|
| 21 |
Redesigning a large school-based clinical trial in response to changes in community practice
|
Gerald, Lynn B
|
|
2011
|
8 |
3 |
p. 311-319
|
artikel
|
| 22 |
Redesigning a large school-based clinical trial in response to changes in community practice
|
Gerald, Lynn B
|
|
2011
|
8 |
3 |
p. 311-319
|
artikel
|
| 23 |
The development and description of the comparison group in the Look AHEAD trial
|
|
|
2011
|
8 |
3 |
p. 320-329
|
artikel
|
| 24 |
The development and description of the comparison group in the Look AHEAD trial
|
,
|
|
2011
|
8 |
3 |
p. 320-329
|
artikel
|
| 25 |
The 6-MP versus placebo clinical trial in acute leukemia
|
Gehan, Edmund A
|
|
2011
|
8 |
3 |
p. 288-297
|
artikel
|
| 26 |
The 6-MP versus placebo clinical trial in acute leukemia
|
Gehan, Edmund A
|
|
2011
|
8 |
3 |
p. 288-297
|
artikel
|
Tijdschrift beschrijving